SUVENPHAR Suven Pharmaceuticals Ltd US FDA Inspections Announcement 2025 - FDA Inspection Report Cohance Lifesciences Ltd received the Establishment Inspection Report from the USFDA for inspections conducted from March 3-7, 2025, classifying it as Voluntary Action Indicated (VAI), indicating the end of the inspection process..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Suven Pharmaceuticals Ltd